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ABSTRACT 
 
 
Background: To inform public health interventions, further investigation is needed to 
identify: (1) frequency/intensity of everyday physical activity (PA) needed to reduce 
dementia risk; (2) whether post-diagnosis reduction in PA is associated with cognitive 
outcomes. Methods: Data from 11,391 men and women (aged ≥50) were obtained in 
the English Longitudinal Study of Ageing. Assessments were at baseline (2002-2003) 
and biannual follow-ups (2004-2013). Results: Older adults who carried out moderate to 
vigorous activity at least once per week had a 34%-50% lower risk for cognitive decline 
and dementia over an 8-10 year follow-up period.  From pre- to post-diagnosis, those 
that decreased PA levels had a larger decrease in immediate recall score, compared to 
those that maintained or increased PA levels (adjusted for changes in physical function). 
Conclusion: These findings provide a guideline for everyday PA levels needed to 
reduce risk for dementia. Reduction in PA after diagnosis was also associated with 
accelerated cognitive decline. 
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1. INTRODUCTION 
 
Dementia is neurodegenerative condition characterised by progressive and marked 
decline in memory and other cognitions. Based on UK data in 2013, dementia 
prevalence was 1.3% in the total population and 7.1% in those over the age of 65 [1]. 
Without significant public health intervention, this was projected to increase by 40% over 
the next 12 years, due to population ageing. Comparatively, current worldwide 
prevalence is estimated at 5.2% in those above age 60 and expected to double within 
20 years, making dementia one of the leading causes of disability and dependence 
globally [2]. Present global economic cost of dementia including medical care (20%), 
social care (40%) and unpaid care e.g. family/friends (40%) is estimated at US$818 
billion [2]. Understanding modifiable lifestyle factors that could prevent or delay disease 
onset will therefore have implications for these economic costs and quality of life for 
those at risk for dementia.  
 
Observational studies and randomized controlled trials provide evidence for the benefits 
of regular physical activity (PA) as a behavioral approach to reduce dementia risk [3–5]. 
PA refers to any bodily movement produced by the skeletal muscles that requires 
energy expenditure [6]. This can include everyday activities (e.g. walking, gardening, 
recreational sports) or targeted exercise training (e.g. gym workout). Several 
neurophysiological mechanisms may elucidate the benefits of physical activity on 
cognitive health. These include increased cerebral blood flow [7], reduced age-related 
loss of brain tissue [8] and increased levels of neurotrophins (particularly brain-derived 
neurotrophic factor; BDNF) associated with synaptic plasticity and neuronal survival [9]. 
PA has also been associated with reduced risk for age-related co-morbidities including 
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cardiovascular disease, stroke, diabetes mellitus and depression, which are also risk 
factors for dementia [10]. However, limitations to interpret studies assessing the 
association between PA and dementia have been consistently noted. A number of 
studies do not adjust for relevant confounders of PA (e.g. alcohol consumption, smoking 
status, depression and cardiovascular factors [4,10–12], potentially exaggerating effect 
size and reducing reliability. Retrospective self-report measures often do not report 
details of frequency and intensity of PA, limiting their clinical applicability[4,11]. Studies 
offering a follow-up of at least 10 years are few, leading to issues with reverse causality, 
where undiagnosed symptoms of dementia may lead to less physical activity rather than 
the opposite [4]. Finally, the association between pre- to post-diagnosis changes in PA 
and cognition has not been previously investigated, but would be valuable to inform 
public health interventions.  
 
The present study investigated the association between PA and dementia risk over a 10-
year follow-up in the English Longitudinal Study of Ageing (ELSA).  
 
2. METHOD 
 
2.1. Participants 
 
ELSA is an ongoing epidemiological study of men and women (≥50 years of age). The 
sample was drawn from those who participated in the Health Survey for England (HSE) 
between 1998-2000. The primary form data collection in ELSA is a computer assisted 
personal interview (CAPI) carried out at the persons home or residence. Details of data 
collection are described elsewhere [13]. The core ELSA cohort included 11,391 
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individuals (46% male, 54% female) who began at baseline (wave 1; 2002-2003) and 
had biannual follow up-interviews (waves 2-6; 2004-2013). Participants with dementia in 
wave 1 were excluded; therefore incident cases of dementia were recorded over waves 
2-6. Participants were also excluded if they were diagnosed with Parkinson’s disease or 
psychiatric ocnditions (e.g. hallucinations, schizophrenia, psychosis), which could 
significantly affect physical or cognitive function. The final sample included 11,289 
participants. All participants gave informed consent before taking part and the London 
Multi-Centre Research Ethics Committee approved this study.  
 
2.2. Physical Activity (PA) Definition 
 
Self-reported PA data were collected using questionnaires administered at each wave. 
Respondents were given examples of PA at mild intensity (e.g. laundry, home repairs), 
moderate intensity (e.g. cleaning the car, walking at a moderate pace) and vigorous 
intensity (e.g. digging with a spade, cycling, aerobics). They were then asked to indicate 
their frequency of participation in mild, moderate and vigorous PA (hardly ever, one to 
three times per month, once per week or more than once per week). Items on the ELSA 
physical activity questionnaire were modified from the Whitehall II Health questionnaire 
[14]. The chosen examples of PA at different intensities were selected as they were 
most commonly reported in two UK-based population studies, carried out in a similar 
age group, namely the Ely Diabetes study and the UK sample from the European 
Prospective Investigation into Cancer (EPIC) cohort [15]. Different PA intensities were 
categorised based the activity’s metabolic equivalent (MET) score [16]. MET scores 
between 2 to 3.5 corresponded to mild PA, scores 3.5 to 6 defined moderate PA and a 
score of greater than 6 was equivalent to vigorous PA.  
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Self-reported data were recorded at each wave (where available). For the purpose of 
this study we further categorized PA into four groups coded with numerical values: (1) 
PA less than once per week (<1x/wk); (2) mild PA once per week (1x/wk); (3) moderate 
or vigorous PA once per week (1x/wk); (4) moderate or vigorous PA twice per week or 
more (>1x/wk). For those without a dementia diagnosis, “average PA” was defined as 
the mean level of PA across waves 1-6. For those with incident dementia, average PA 
was defined as the mean level of PA using only the waves prior to diagnosis.  
 
2.3. Dementia Assessment 
 
Dementia was defined as a physician diagnosis of dementia or Alzheimer’s disease 
reported by the participant in the CAPI. If the individual was unable to take part in the 
CAPI for any reason, a family member or long-term carer was able to complete the 
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) [17]. The 
IQCODE consists of 26 questions, which ask the informant to rate how their friend or 
relative is in situations now compared to 10 years ago (e.g. “recognising faces of family 
and friends”, “remembering things that have happened recently”). Scores range on a 5-
point scale from “1=much improved” to “5=much worse”. Scores for each question are 
summed and divided by 26 to give a final score between 1-5. Scores above 3.5 were a 
cut-off for identifying dementia cases. The IQCODE has been shown to be a valid 
predictor of dementia [18] performing as well as other commonly used screening 
methods (e.g. Mini-Mental State Examination (MMSE) [19]).  
 
2.4 Covariates 
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Several baseline factors were accounted for as possible covariates that could affect 
cognition, physical activity or health status [10,20]. Demographic factors included age 
(years) and gender (male/female). Socioeconomic variables were derived for education 
(degree level/below degree/no qualification) and wealth (3rd quintile or less [least 
wealthy]//4th quintile or above [most wealthy]). Wealth was calculated as net of debt and 
included the value of housing (excluding mortgage), financial assets (e.g. savings, 
business assets) and physical wealth (e.g. artwork, jewelry). Presences of several self-
reported doctor diagnosed cardiovascular disease factors were accounted for, including 
high blood pressure, diabetes, stroke and heart attack (binary yes/no). In sensitivity 
analysis, binary variables for presence of any self-reported doctor-diagnosed heart 
condition (including the latter cardiovascular factors plus any other reported) or chronic 
disease (lung disease, asthma, osteoporosis, cancer, neurological or psychiatric 
problems) were included. Depressive symptoms were assessed using an eight-tem 
Epidemiological Studies Depression Scale (CES-D) validated for use in older adults [21]. 
Here, a CES-D score of 4 or higher identified elevated symptoms of major depression. 
Other health related covariates included smoking status (non-smoker/previous 
smoker/current smoker) and frequency of alcohol consumption (more than once daily/ 
daily/ one to two times per week/ less than once per week). Validated 
neuropsychological measures of cognition [20] included immediate recall (of 10 words in 
a list) and verbal fluency (naming category items in 1 minute i.e. animals). Finally, 
physical function was measured using gait speed, defined as the time in seconds taken 
to walk a course of 2.44 meters (averaged across 2 trials). 
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2.5. Statistical Analysis 
 
Descriptive analyses were performed on data stratified by incidence of dementia. Chi-
squared statistics were computed to assess baseline group differences for categorical 
data and independent samples t-statistics were used for continuous data.  
 
The association between PA and dementia risk was estimated using Cox proportional 
hazards regression, calculating multivariate-adjusted hazards ratios (HR’s) with 95% 
confidence intervals (CI’s). The timescale variable was the number of completed 
assessment waves and the censor variable was whether a dementia diagnosis was 
reported (yes/no). Separate models were used to predict dementia risk from (i) baseline 
PA and (ii) average PA levels across the follow-up period. Covariates were adjusted in a 
step-wise approach. In the first step, models contained variables for age, gender, 
education, wealth, baseline cognitive function and physical function. The second step 
adjusted for additional variables including alcohol consumption, smoking status, 
depression, mood problems, cardiovascular factors and chronic disease. In sensitivity 
analysis exclusion criteria were manipulated to assess the possibility of reverse 
causality. Here, participants were excluded if they had a dementia diagnosis in waves 1-
2 (i.e. up to two years since baseline). This examined robustness of findings and 
reduced the likelihood that undiagnosed prodromal symptoms of dementia contributed to 
decreased PA, rather than the opposite. Imputation methods were not performed on 
missing data.  
 
Subgroup analysis was carried out in those with dementia, who carried out an average 
of moderate/vigorous at least once per week before diagnosis. Multivariate regression 
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was used to investigate whether reduction in PA after diagnosis were associated with 
cognitive outcomes (immediate recall and verbal fluency). Here, delta change (∆) scores 
were calculated as post-diagnosis minus pre-diagnosis score. Age, gender, education, 
and changes in physical function (pre- to post-diagnosis) were also controlled for.  
 
In sensitivity analysis exclusion criteria were manipulated to assess the possibility of 
reverse causality. In the first analysis, participants were excluded if they had a dementia 
diagnosis in waves 1-2 (i.e. up to 2 years since baseline). This examined robustness of 
findings and reduced the likelihood that undiagnosed prodromal symptoms of dementia 
contributed to decreased PA, rather than the opposite. In the second analysis, 
participants were excluded if they had any type of chronic disease at baseline that could 
affect PA levels.  
 
In all analyses, two-sided p values are reported and values ≤0.05 were considered 
statistically significant. Analyses were performed using IBM SPSS Statistics (Version 
22).  
 
 
3. RESULTS 
Of the core-interviewed participants (N=11,391), 2,576 participants died and 3,156 were 
lost over the follow-up period (e.g. moved out of UK, became institutionalised and were 
unproductive, were unable/unwilling to continue with study) (see Figure 1).  
 
Compared to those who left the study, participants with data available in final wave 
(N=5659) tended to be younger, female, more physically active, wealthier, have a higher 
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educational level and score higher on measures of cognitive and physical function at 
baseline. They also consumed more alcohol, but were less likely to smoke or have 
reported a psychiatric condition, cardiovascular condition or chronic disease at baseline.  
 
3.1. Baseline PA and incident dementia 
 
For the included sample (N=11,289), the cohort was divided into those that received a 
dementia diagnosis (across waves 2-6) versus those that did not. Approximately 3.5% of 
the sample received a dementia diagnosis. Baseline characteristics for the sample are 
outlined in Table 1.  
 
In cox proportional hazards regression (see Table 2), PA levels were independently 
associated with dementia incidence in a dose-dependant manner. In the fully adjusted 
model, mild PA 1x/wk (multivariate adjusted HR=0.69, 95%CI=0.50–0.95, p=0.02), 
moderate/vigorous PA 1x/wk (multivariate adjusted HR=0.66, 95%CI=0.46–0.94, 
p=0.02) and moderate/vigorous PA >1x/wk (multivariate adjusted HR=0.50, 
95%CI=0.37–0.67, p<0.001) lowered the HR for dementia, compared to those that 
reported doing PA<1x/wk.  
 
3.2. Average PA levels (across follow-up) and incident dementia 
 
Average PA levels before diagnosis in those with incident dementia (2.63 ± 0.05; i.e. 
mild PA 1x/wk) were lower than the average PA levels of those with no diagnosis (3.17 ± 
0.01; i.e. moderate/vigorous PA 1x/wk) (p<0.001). Trajectory of PA levels across all 
waves (stratified by diagnosis) is illustrated in supplementary Figure 1. In cox 
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proportional hazards analyses, higher average PA levels across the follow-up period 
lowered the HR for dementia (full multivariate adjusted HR=0.79, 95%CI=0.69–0.91, 
p=0.001) (see Table 3).  
 
3.3. Subgroup analysis  
 
In those with dementia, mean PA levels, immediate recall score and verbal fluency score 
dropped from pre- to post-diagnosis (p≤0.01) (see supplementary Table 1). This was the 
case even though physical function appeared to increase (i.e. quicker walking speed). 
Those who were active before diagnosis (i.e. averaged ≥ moderate/vigorous PA 1x/wk) 
but reduced their PA levels after diagnosis (N=282), had a larger drop in immediate 
recall score from pre- to post-diagnosis (ß=0.41, p<0.001), in comparison to those who 
maintained or increased their PA levels (see Table 4 and Figure 2). The decrease in PA 
was proportionate to decrease in cognitive score. This association was independent of 
changes in physical function, age, gender and education. Although not statistically 
significant, there was a similar trend between PA and verbal fluency. 
 
3.4. Sensitivity analysis 
 
Excluding anyone with a dementia diagnosis at waves 1-2 reduced the possibility of 
reverse causality. After exclusion, there were 271 remaining dementia cases (total 
sample N=8,564), which decreased the power to detect significant effects. In basic and 
fully adjusted models, lower levels of PA independently increased the HR for dementia. 
However, the effect of moderate/vigorous PA became marginally significant (multivariate 
adjusted HR=0.69, 95%CI=0.46–1.04, p=0.07). In the fully adjusted model, mild PA 
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1x/wk (multivariate adjusted HR=0.66, 95%CI=0.45–0.96, p=0.03) and 
moderate/vigorous PA>1x/wk (multivariate adjusted HR=0.51, 95%CI=0.35–0.72, 
p<0.001) lowered the HR for dementia, compared to those that reported doing 
PA<1x/wk. Higher average PA levels (across the follow-up) also reduced dementia risk 
(full multivariate adjusted HR=0.80, 95%CI=0.68–0.94, p=0.01). Therefore, dementia 
incidence up to two years after baseline assessment did not significantly affect the 
association between PA and dementia risk.  
 
4. DISCUSSION 
 
Using prospective longitudinal data from the ELSA cohort, the present study examined 
the association between self-reported PA and dementia over a 10-year follow-up period. 
In the present study, PA was associated with a lowered the risk for dementia in a dose-
dependent manner. Here, moderate/vigorous PA>1x/wk appeared to be the most risk 
reducing, followed by moderate/vigorous PA 1x/wk and then mild PA 1x/wk. These 
findings were replicated in models adjusted for lifestyle and clinical covariates. Results 
also remained consistent in sensitivity analysis that reduced the possibility of reverse 
causality, although the effect of moderate/vigorous PA 1x/wk became marginally 
significant, possibly due to the lower sample size and reduced power to detect effects. 
The present results support previous analysis within this cohort, which found that higher 
levels of PA predicted healthy ageing, including survival from major chronic disease, 
depressive symptoms, physical or cognitive impairment [20]. This study also validates a 
number of longitudinal studies, which have found an association between higher levels 
of PA and reduced risk for dementia and cognitive dysfunction [4].  
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A novel finding was observed in those who were active before dementia diagnosis (i.e. 
carried out ≥ moderate/vigorous activity 1x/wk), but reduced their PA levels after 
diagnosis. In this subgroup, those who reduced PA levels after diagnosis had a larger 
drop in immediate recall score (pre- to post-diagnosis), compared to those who 
maintained or increased their PA levels. Furthermore, those with larger decreases in PA 
after diagnosis had a correspondingly larger decrease in recall score. This did not 
appear to be explained by changes in physical function. It is possible that reduction in 
PA levels after dementia diagnosis is due to loss of confidence or anxiety associated 
with cognitive symptoms of dementia (i.e. confusion, memory loss, disorientation). On 
the other hand, it could also be caused by the stigma of having dementia or perceived 
dependency on carers for day-to-day activities [22]. Further research with a larger 
sample size is needed to investigate the reasons why those who were active before 
diagnosis may become less active after diagnosis, as this will provide insight into public 
health intervention adherence. Even still, these results suggest that maintenance of PA 
after dementia diagnosis may be beneficial for memory.  
 
Neuroimaging studies and randomised controlled trials provide biological plausibility for 
the neuroprotective effects of regular PA. Regular PA is associated with increased 
hippocampal, prefrontal cortex and basal ganglia brain volumes, increased white matter 
integrity, as well as increased brain function and connectivity between frontal and 
hippocampal brain regions [23]. Additionally, both animal and human studies suggest 
that exercise induced increases in BDNF may promote neurite outgrowth even in older 
adults [24,25]. It is theorised that these neuroprotective factors may all contribute to an 
individuals cognitive reserve; meaning that regular PA may increase a persons ability to 
recruit compensatory cognitive processing in order to reduce the effects of brain 
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pathology [26]. Indeed, mechanisms contributing to neurodegeneration in dementia 
include synaptic loss, neuronal death, inflammation and accumulation of toxic β-amyloid 
plaques and intracellular neurofibrillary tangles. Regular PA has been shown to alleviate 
or delay pathogenesis of dementia [27]. 
 
Limitations of the present study are acknowledged. Firstly, self-reported measures of PA 
have been criticised, as adults may not adequately recall PA, particularly low-intensity 
activities [28]. Therefore, despite our large effect sizes we may have underestimated the 
strength of the effects of PA in this study due to regression dilution bias [4]. Secondly, 
within the present sample, 3.5% of participants were classified as having dementia. 
Given the average age of our sample at baseline (62 ± 0.1), dementia incidence is 
slightly lower than reported national prevalence rates [1]. There is evidence that 
approximately half of the cases of dementia in the UK remain undiagnosed [1] meaning 
that physician diagnosis may underestimate dementia prevalence rates in our sample. 
Physician diagnosis of dementia reported in the CAPI was not formally validated and so 
results must be interpreted with this consideration in mind. Moreover, those with 
dementia or experiencing symptoms of dementia may have chosen not to participate in 
this study or may have been excluded in the baseline wave leading to further attrition 
bias, which may have led to an underestimation of effect size.  
 
Finally, in the present study, only complete cases were included in regression analyses. 
Imputation methods were not used and missing data (due to death or loss to follow-up) 
may have impacted the study findings. Those with available data throughout the study 
follow-up period (waves 1 to 6) were more likely to be younger, female, more physically 
active, wealthier, have a higher educational level and score higher on measures of 
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cognitive and physical function at baseline; they also consumed more alcohol, but were 
less likely to smoke or have reported a psychiatric condition, cardiovascular condition or 
chronic disease at baseline. Therefore results of this study must be interpreted in the 
context of this missing data. For instance, participants that had the lowest cognitive or 
physical ability may have been less likely to be represented in the final sample. 
Nevertheless, in clinical practice, PA lifestyle interventions would be designed to target 
populations prior to disease onset or cases were disease activity is in its earliest stages 
and disease progression is limited. Therefore, although the final sample may be biased 
towards a healthier population, these participants would also be those who would be 
most likely to carry out and benefit from a PA intervention designed to maintain cognitive 
health in older age.  
 
This study also has a number of important strengths, including the ability to utilise 
longitudinal data from a large cohort. Sensitivity analysis in a recent meta-analysis [4], 
found that only 7 of 26 reviewed cohort studies had a follow-up period of greater than 
ten years and the majority of these investigated risk for cognitive decline rather than 
dementia. Furthermore, studies tended to look at the relationship between baseline PA 
and incident dementia (many years later) without consideration of intermediary time-
points. The present data is rare in that repeated measures of PA were taken at a 
number of regular intervals across the follow-up period and in synchrony with recorded 
dementia diagnosis. Furthermore, a definition of PA was used that outlined both intensity 
and frequency of activity, and this is relevant for increasing the clinical applicability of 
these findings. To inform intervention guidelines, the present study found that average 
PA levels in those without cognitive impairment or dementia remained above moderate 
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to vigorous PA 1x/wk. Moderate PA includes any type of activity with a MET score of 
3.5-6 and vigorous PA includes activity with a MET score above 6.  
 
Overall, maintaining higher levels of PA in older age was associated with decreased risk 
for dementia. For those who were active before diagnosis, reducing PA levels after 
diagnosis may be detrimental for dementia prognosis, however further research is 
needed to investigate this possibility.  
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TABLES 
Table 1. Characteristics of the population at baseline 
 No incident 
dementia 
 
Incident 
dementia 
 
Sig. 
 
Age; years 
 
 
N = 10,746 
64.80 ± 0.09 
 
N = 388 
75.59 ± 0.45 
 
<0.001 
 
Gender  
   Male 
   Female 
 
N = 10,746 
46 
54 
 
N = 388 
42 
58 
 
0.16 
 
Education 
   Degree or equivalent  
   Below degree 
   No qualification 
 
N = 10,722 
11 
47 
42 
 
N = 385 
7 
35 
58 
 
<0.001 
 
Verbal Fluency 
 
 
N = 10,489 
19.36 ± 0.06 
 
N = 367 
15.25 ± 0.29 
 
<0.001 
 
Immediate Recall 
 
 
N = 10,487 
5.47 ± 0.02 
 
 
N = 370 
4.07 ± 0.09 
 
<0.001 
Walking speed; seconds  
 
N = 10,746 
1.39 ± 0.11 
N = 388 
2.73 ± 0.87 
0.03 
 
Baseline PA 
   Moderate/vigorous >1x per wk 
   Moderate/vigorous 1x per wk 
   Mild 1x per wk 
   PA < 1x per wk 
 
 
N = 10,647 
60 
15 
15 
10 
 
 
N = 378 
42 
16 
22 
20 
 
<0.001 
Wealth; quintiles 
   <3rd  
   4th or 5th 
N = 10,551 
59 
41 
 
N = 386 
69 
31 
 
<0.001 
Smoking status 
   Current 
   Previous 
   Never 
N = 10,654 
18 
47 
35 
N = 378 
12 
50 
38 
 
0.02 
Alcohol consumption 
   >1x daily 
   Daily 
   1-2x per wk 
   <1x per wk 
N = 10,652 
4 
24 
31 
41 
N = 377 
4 
19 
26 
51 
0.003 
 
Depression 
   Yes 
   No 
 
N = 10,746 
5 
95 
 
N = 388 
4 
96 
 
0.29 
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Mood problem 
   Yes 
   No 
 
N = 10,746 
5 
95 
N = 388 
3 
97 
0.23 
Cardiovascular condition 
   Yes 
   No 
 
N = 10,744 
50 
50 
N = 388 
71 
29 
<0.001 
Chronic disease 
   Yes 
   No 
 
N = 10,746 
50 
50 
N = 388 
58 
42 
0.003 
*For categorical data crosstabs indicate percentages for each category. For continuous data mean (± 
SEM) is included. The cohort is divided into those with and without dementia diagnosis between ELSA 
waves 2-6. 
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Table 2. Cox proportional hazards regression to predict dementia risk from baseline PA 
(N=10,663) 
 
 STEP 1 STEP 2 
 
 HR 95% CI Sig. HR 95% CI Sig. 
 
Baseline PA 
   Moderate/vigorous >1x per wk 
   Moderate/vigorous 1x per wk 
   Mild 1x per wk 
   PA < 1x per wk 
 
 
0.50 
0.66 
0.69 
[Ref] 
 
 
0.37-0.67 
0.46-0.94 
0.50-0.95 
 
 
<0.001 
0.02 
0.02 
 
 
 
0.51 
0.66 
0.67 
[Ref] 
 
 
0.38-0.70 
0.46-0.94 
0.49-0.93 
 
 
<0.001 
0.02 
0.02 
 
 
Age; years 
 
1.11 1.10-1.12 <0.001 1.11 1.10-1.13 <0.001 
Gender  
   Male 
   Female 
 
 
1.13 
[Ref] 
 
0.91-1.40 
 
0.29 
 
1.10 
[Ref] 
 
0.87-1.39 
 
0.41 
Education 
   Degree or equivalent 
   Below degree 
   No qualification 
 
 
1.15 
1.01 
[Ref] 
 
0.72-1.85 
0.80-1.27 
 
0.56 
0.95 
 
1.18 
1.01 
[Ref] 
 
0.73-1.90 
0.80-1.27 
 
0.50 
0.94 
Wealth; quintiles 
   <3rd  
   4th or 5th 
 
 
1.14 
[Ref] 
 
0.90-1.46 
 
0.28 
 
1.09 
[Ref] 
 
0.84-1.40 
 
0.53 
Verbal fluency 
 
0.95 0.93-0.97 <0.001 0.95 0.93-0.97 <0.001 
Immediate recall 
 
0.78 0.73-0.84 <0.001 0.78 0.73-0.83 <0.001 
Physical function 1.00 
 
0.99-1.01 0.80 1.00 0.99-1.01 0.76 
STEP 1: Adjusted for baseline PA, age, gender, education, wealth, cognitive function, physical function 
STEP 2: Adjusted for baseline PA, age, gender, education, wealth, cognitive function, physical function, smoking 
status, alcohol consumption, depression, mood problems, cardiovascular conditions and chronic disease 
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Table 3. Cox proportional hazards regression to predict dementia risk from average 
PA levels across the follow-up (N=10,667) 
 
 STEP 1 STEP 2 
 
 HR 95% CI Sig. HR 95% CI Sig. 
 
Average PA*  0.79 0.69-0.90 <0.001 
 
0.82 
 
0.72-0.94 
 
0.01 
 
Age; years 
 
1.11 1.10-1.12 <0.001 1.11 1.10-1.12 <0.001 
Gender  
   Male 
   Female 
 
 
1.15 
[Ref] 
 
0.92-1.43 
 
0.21 
 
1.12 
[Ref] 
 
0.89-1.42 
 
0.33 
Education 
   Degree or equivalent 
   Below degree 
   No qualification 
 
 
1.15 
1.01 
[Ref] 
 
0.72-1.85 
0.80-1.28 
 
0.56 
0.92 
 
1.17 
1.01 
[Ref] 
 
0.73-1.88 
0.80-1.27 
 
0.52 
0.93 
Wealth; quintiles 
   <3rd  
   4th or 5th 
 
 
1.13 
[Ref] 
 
0.88-1.45 
 
0.33 
 
1.08 
[Ref] 
 
0.84-1.39 
 
0.54 
Verbal fluency 0.95 0.93-0.97 <0.001 0.95 0.93-0.97 <0.001 
 
Immediate recall 
 
 
0.78 
 
0.73-0.84 
 
<0.001 
 
0.78 
 
0.73-0.83 
 
<0.001 
Physical function 
 
1.00 0.99-1.01 0.71 1.00 0.99-1.01 0.69 
* In those with dementia diagnosis, average PA is calculated using only waves prior to diagnosis 
STEP 1: Adjusted for average PA, age, gender, education, wealth, cognitive function, physical function 
STEP 2: Adjusted for average PA, age, gender, education, wealth, cognitive function, physical function, smoking 
status, alcohol consumption, depression, mood problems, cardiovascular conditions and chronic disease  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
25 
Table 4. Multiple regression to predict scores on immediate recall and verbal fluency 
measures.  Coefficients (ß) and significance values (sig.) are reported 
  
  
Cognitive outcome 
 
  
Δ Immediate recall 
(N=127) 
 
Δ Verbal fluency 
(N=67) 
 
  
ß 
 
Sig 
 
ß 
 
Sig 
 
Δ Physical activity 
 
0.51 
 
<0.001 
 
0.94 
 
0.08 
 
Δ Physical function 
  
0.19 
 
<0.001 
 
-0.06 
 
0.82 
 
Age 
 
0.03 
 
0.19 
 
-0.01 
 
0.91 
 
Gender 
 
-0.15 
 
0.64 
 
0.93 
 
0.44 
 
Education 
 
0.58 
 
0.02 
 
1.69 
 
0.09 
 
Δ = Delta change score (post- minus pre-diagnosis value) 
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FIGURE 1 
 
 
 
Figure 1. Flowchart of available data (N) in each wave 
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FIGURE 2 
 
 
 
 
 
Figure 2. Changes in immediate recall score and PA levels from pre- to post-diagnosis. 
Negative values show a decrease, whereas positive values indicate an increase.  
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Supplementary Figure 1. Mean category response for self-reported PA (± SEM) 
stratified by dementia diagnosis, at waves 1-6. PA categories: 1 = no PA at least once 
per week; 2 = mild PA once per week; 3 = moderate or vigorous PA once per week; 4 = 
moderate or vigorous PA two times per week or more.  
 
 
 
 
Supplementary Table 1. Mean (±SEM) values for cognitive function, 
physical function and physical activity levels pre-diagnosis and post-
diagnosis. These participants carried out moderate/vigorous PA at least 
1x/wk prior to diagnosis (N=282) 
 
  
Dementia diagnosis 
 
 
  
Pre 
 
Post 
 
Sig. 
Verbal fluency 
 
15.50 ± 0.49 
 
10.13 ± 0.57 
 
<0.001 
Immediate recall 
 
4.05 ± 0.11 
 
1.79 ± 0.15 
 
0.001 
Physical function 
 
4.64 ± 0.24 
 
3.55 ± 0.32 
 
0.001 
Physical activity 
 
2.64 ± 0.06 
 
1.56 ± 0.05 
 
<0.001 
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